Industry: Chemical & Material
Published Date: 2026-02-01
Pages: 134 Pages
Report ld: 5845752
Request Sample
Customized Report
Pharmaceutical Grade Niacin Market Size(US$)

CAGR 2026-2032
5.1%
Market Size,2032
USD 965
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharmaceutical Grade Niacin market was valued at US$ 683 million in 2025 and is anticipated to reach US$ 965 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Pharmaceutical Grade Niacin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Pharmaceutical Grade Niacin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharmaceutical Grade Niacin. The Pharmaceutical Grade Niacin market size, estimates, and forecasts are provided in terms of output/shipments (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharmaceutical Grade Niacin market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharmaceutical Grade Niacin manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Pharmaceutical Grade Niacin manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Pharmaceutical Grade Niacin production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Pharmaceutical Grade Niacin consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Pharmaceutical Grade Niacin Market Overview
1.1 Product Definition
1.2 Pharmaceutical Grade Niacin by Type
1.2.1 Global Pharmaceutical Grade Niacin Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Crystal
1.2.3 Powder
1.3 Pharmaceutical Grade Niacin by Application
1.3.1 Global Pharmaceutical Grade Niacin Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Pharmaceutical Industry
1.3.3 Daily Chemicals
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Pharmaceutical Grade Niacin Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Pharmaceutical Grade Niacin Production Estimates and Forecasts (2021–2032)
1.4.4 Global Pharmaceutical Grade Niacin Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical Grade Niacin Production Market Share by Manufacturers (2021–2026)
2.2 Global Pharmaceutical Grade Niacin Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Pharmaceutical Grade Niacin, Industry Ranking, 2024 vs 2025
2.4 Global Pharmaceutical Grade Niacin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Pharmaceutical Grade Niacin Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Pharmaceutical Grade Niacin, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Pharmaceutical Grade Niacin, Product Offerings and Applications
2.8 Global Key Manufacturers of Pharmaceutical Grade Niacin, Date of Entry into the Industry
2.9 Pharmaceutical Grade Niacin Market Competitive Situation and Trends
2.9.1 Pharmaceutical Grade Niacin Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Pharmaceutical Grade Niacin Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Pharmaceutical Grade Niacin Production by Region
3.1 Global Pharmaceutical Grade Niacin Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Pharmaceutical Grade Niacin Production Value by Region (2021–2032)
3.2.1 Global Pharmaceutical Grade Niacin Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Pharmaceutical Grade Niacin by Region (2027–2032)
3.3 Global Pharmaceutical Grade Niacin Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Pharmaceutical Grade Niacin Production Volume by Region (2021–2032)
3.4.1 Global Pharmaceutical Grade Niacin Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Pharmaceutical Grade Niacin by Region (2027–2032)
3.5 Global Pharmaceutical Grade Niacin Market Price Analysis by Region (2021–2026)
3.6 Global Pharmaceutical Grade Niacin Production, Value, and Year-over-Year Growth
3.6.1 North America Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Pharmaceutical Grade Niacin Production Value Estimates and Forecasts (2021–2032)
4 Pharmaceutical Grade Niacin Consumption by Region
4.1 Global Pharmaceutical Grade Niacin Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Pharmaceutical Grade Niacin Consumption by Region (2021–2032)
4.2.1 Global Pharmaceutical Grade Niacin Consumption by Region (2021–2026)
4.2.2 Global Pharmaceutical Grade Niacin Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Pharmaceutical Grade Niacin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Pharmaceutical Grade Niacin Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharmaceutical Grade Niacin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Pharmaceutical Grade Niacin Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharmaceutical Grade Niacin Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Pharmaceutical Grade Niacin Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharmaceutical Grade Niacin Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Pharmaceutical Grade Niacin Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharmaceutical Grade Niacin Production by Type (2021–2032)
5.1.1 Global Pharmaceutical Grade Niacin Production by Type (2021–2026)
5.1.2 Global Pharmaceutical Grade Niacin Production by Type (2027–2032)
5.1.3 Global Pharmaceutical Grade Niacin Production Market Share by Type (2021–2032)
5.2 Global Pharmaceutical Grade Niacin Production Value by Type (2021–2032)
5.2.1 Global Pharmaceutical Grade Niacin Production Value by Type (2021–2026)
5.2.2 Global Pharmaceutical Grade Niacin Production Value by Type (2027–2032)
5.2.3 Global Pharmaceutical Grade Niacin Production Value Market Share by Type (2021–2032)
5.3 Global Pharmaceutical Grade Niacin Price by Type (2021–2032)
6 Segment by Application
6.1 Global Pharmaceutical Grade Niacin Production by Application (2021–2032)
6.1.1 Global Pharmaceutical Grade Niacin Production by Application (2021–2026)
6.1.2 Global Pharmaceutical Grade Niacin Production by Application (2027–2032)
6.1.3 Global Pharmaceutical Grade Niacin Production Market Share by Application (2021–2032)
6.2 Global Pharmaceutical Grade Niacin Production Value by Application (2021–2032)
6.2.1 Global Pharmaceutical Grade Niacin Production Value by Application (2021–2026)
6.2.2 Global Pharmaceutical Grade Niacin Production Value by Application (2027–2032)
6.2.3 Global Pharmaceutical Grade Niacin Production Value Market Share by Application (2021–2032)
6.3 Global Pharmaceutical Grade Niacin Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Lonza
7.1.1 Lonza Pharmaceutical Grade Niacin Company Information
7.1.2 Lonza Pharmaceutical Grade Niacin Product Portfolio
7.1.3 Lonza Pharmaceutical Grade Niacin Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Lonza Main Business and Markets Served
7.1.5 Lonza Recent Developments/Updates
7.2 Jubilant Life Sciences
7.2.1 Jubilant Life Sciences Pharmaceutical Grade Niacin Company Information
7.2.2 Jubilant Life Sciences Pharmaceutical Grade Niacin Product Portfolio
7.2.3 Jubilant Life Sciences Pharmaceutical Grade Niacin Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Jubilant Life Sciences Main Business and Markets Served
7.2.5 Jubilant Life Sciences Recent Developments/Updates
7.3 Vertellus
7.3.1 Vertellus Pharmaceutical Grade Niacin Company Information
7.3.2 Vertellus Pharmaceutical Grade Niacin Product Portfolio
7.3.3 Vertellus Pharmaceutical Grade Niacin Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Vertellus Main Business and Markets Served
7.3.5 Vertellus Recent Developments/Updates
7.4 Brother Enterprises
7.4.1 Brother Enterprises Pharmaceutical Grade Niacin Company Information
7.4.2 Brother Enterprises Pharmaceutical Grade Niacin Product Portfolio
7.4.3 Brother Enterprises Pharmaceutical Grade Niacin Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Brother Enterprises Main Business and Markets Served
7.4.5 Brother Enterprises Recent Developments/Updates
7.5 Zhejiang Lanbo Biotechnology
7.5.1 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Company Information
7.5.2 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Product Portfolio
7.5.3 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Zhejiang Lanbo Biotechnology Main Business and Markets Served
7.5.5 Zhejiang Lanbo Biotechnology Recent Developments/Updates
7.6 Lasons India
7.6.1 Lasons India Pharmaceutical Grade Niacin Company Information
7.6.2 Lasons India Pharmaceutical Grade Niacin Product Portfolio
7.6.3 Lasons India Pharmaceutical Grade Niacin Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Lasons India Main Business and Markets Served
7.6.5 Lasons India Recent Developments/Updates
7.7 Vanetta
7.7.1 Vanetta Pharmaceutical Grade Niacin Company Information
7.7.2 Vanetta Pharmaceutical Grade Niacin Product Portfolio
7.7.3 Vanetta Pharmaceutical Grade Niacin Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Vanetta Main Business and Markets Served
7.7.5 Vanetta Recent Developments/Updates
7.8 DSM
7.8.1 DSM Pharmaceutical Grade Niacin Company Information
7.8.2 DSM Pharmaceutical Grade Niacin Product Portfolio
7.8.3 DSM Pharmaceutical Grade Niacin Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 DSM Main Business and Markets Served
7.8.5 DSM Recent Developments/Updates
7.9 Tianjin Zhongrui Pharmaceutical
7.9.1 Tianjin Zhongrui Pharmaceutical Pharmaceutical Grade Niacin Company Information
7.9.2 Tianjin Zhongrui Pharmaceutical Pharmaceutical Grade Niacin Product Portfolio
7.9.3 Tianjin Zhongrui Pharmaceutical Pharmaceutical Grade Niacin Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Tianjin Zhongrui Pharmaceutical Main Business and Markets Served
7.9.5 Tianjin Zhongrui Pharmaceutical Recent Developments/Updates
7.10 Resonance Specialties
7.10.1 Resonance Specialties Pharmaceutical Grade Niacin Company Information
7.10.2 Resonance Specialties Pharmaceutical Grade Niacin Product Portfolio
7.10.3 Resonance Specialties Pharmaceutical Grade Niacin Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Resonance Specialties Main Business and Markets Served
7.10.5 Resonance Specialties Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharmaceutical Grade Niacin Industry Chain Analysis
8.2 Pharmaceutical Grade Niacin Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharmaceutical Grade Niacin Production Modes and Processes
8.4 Pharmaceutical Grade Niacin Sales and Marketing
8.4.1 Pharmaceutical Grade Niacin Sales Channels
8.4.2 Pharmaceutical Grade Niacin Distributors
8.5 Pharmaceutical Grade Niacin Customer Analysis
9 Pharmaceutical Grade Niacin Market Dynamics
9.1 Pharmaceutical Grade Niacin Industry Trends
9.2 Pharmaceutical Grade Niacin Market Drivers
9.3 Pharmaceutical Grade Niacin Market Challenges
9.4 Pharmaceutical Grade Niacin Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 683 million in 2025 and is projected to reach US$ 965 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-02-01
Pages: 105
USD 3950.00
(Single User License)
The global Pharmaceutical Grade Niacin market is projected to grow from US$ 653 million in 2024 to US$ 922 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 136
USD 4900.00
(Single User License)
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 91
USD 3950.00
(Single User License)
The global Pharmaceutical Grade Niacin market size was US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 80
USD 4250.00
(Single User License)
The global market for Pharmaceutical Grade Niacin was valued at US$ 653 million in the year 2024 and is projected to reach a revised size of US$ 922 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-02-14
Pages: 94
USD 2900.00
(Single User License)
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published Date: 2024-04-10
Pages: 112
USD 4900.00
(Single User License)
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published Date: 2024-02-05
Pages: 96
USD 2900.00
(Single User License)
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published Date: 2024-01-25
Pages: 122
USD 3950.00
(Single User License)
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 683 million in 2025 and is projected to reach US$ 965 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-02-01
Pages: 105
The global Pharmaceutical Grade Niacin market is projected to grow from US$ 653 million in 2024 to US$ 922 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 136
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 91
The global Pharmaceutical Grade Niacin market size was US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 80
The global market for Pharmaceutical Grade Niacin was valued at US$ 653 million in the year 2024 and is projected to reach a revised size of US$ 922 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-02-14
Pages: 94
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published: 2024-04-10
Pages: 112
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published: 2024-02-05
Pages: 96
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published: 2024-01-25
Pages: 122
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now